CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453728228
- Phone
- 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- 4 Open-market sale Chief Technology Officer sold 6,228 shares at $1.93 ($12,020)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Technology Officer sold 3,147 shares at $1.96 ($6,168)
- 4 Open-market sale Chief Legal Officer sold 6,938 shares at $1.96 ($13,598)
- 4 Open-market sale Chief Business Officer sold 6,938 shares at $1.96 ($13,598)
- 4 Planned sale Chief Medical Officer sold 1,066 shares at $1.96 ($2,089)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 55,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 151,700 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Results of operations · Regulation FD disclosure · Other events
Page 2 of 17 · 326 filings